Post-traumatic Stress Disorder Post Partum: The Impact of Birth on the Prevalence of Post-traumatic Stress Disorder (PTSD) in Multiparous Women

Tekijä Schwab, W., Marth, C., Bergant, A. M.
Julkaistu 2012

Expression of STAT1 target genes and interferon gamma in human mammary carcinoma tissue

Tekijä Doppler, W, Marth, C, Daxenbichler, G, Obrist, P, Berlato, C
Julkaisussa Breast Cancer Res (2005)

Incidental (Prophylactic) Salpingectomy at Benign Gynecologic Surgery and Cesarean Section: a Survey of Practice in Austria

Tekijä Potz, F. L., Tomasch, G., Polterauer, S., Laky, R., Marth, C., Tamussino, K.
Julkaisussa Geburtshilfe Frauenheilkd (2016)

Marked improvement in the success rate of medical management of early pregnancy failure following the implementation of a novel institutional protocol and treatment guidelines: a f...

Tekijä Colleselli, V., Nell, T., Bartosik, T., Brunner, C., Ciresa-Koenig, A., Wildt, L., Marth, C., Seeber, B.
Julkaisussa Arch Gynecol Obstet (2016)

Precancerous Lesions of the Cervix, Vulva and Vagina According to the 2014 WHO Classification of Tumors of the Female Genital Tract

Tekijä Reich, O., Regauer, S., Marth, C., Schmidt, D., Horn, L.-C., Dannecker, C., Menton, M., Beckmann, M. W.
Julkaisussa Geburtshilfe Frauenheilkd (2015)

Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1.

Tekijä Offner, F. A., Feichtinger, H., Stadlmann, S., Obrist, P., Marth, C., Klingler, P., Grage, B., Schmahl, M., Knabbe, C.
Julkaistu 1996

High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.

Tekijä Zeimet, A. G., Widschwendter, M., Uhl-Steidl, M., Müller-Holzner, E., Daxenbichler, G., Marth, C., Dapunt, O.
Julkaistu 1997

Does thyroid-stimulating hormone influence the prognosis of patients with endometrial cancer? A multicentre trial

Tekijä Seebacher, V, Hofstetter, G, Polterauer, S, Reinthaller, A, Grimm, C, Schwameis, R, Taucher, S, Wagener, A, Marth, C, Concin, N
Julkaistu 2013

Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: safety and two-year efficacy results from a multicentre, single-arm, phase II study

Tekijä Sehouli, J, Reinthaller, A, Marth, C, Reimer, D, Reimer, T, Stummvoll, W, Angleitner-Boubenizek, L, Brandt, B, Chekerov, R
Julkaistu 2014

MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status

Tekijä Müller, H M, Fiegl, H, Goebel, G, Hubalek, M M, Widschwendter, A, Müller-Holzner, E, Marth, C, Widschwendter, M
Julkaistu 2003

Nomogram prediction for overall survival of patients diagnosed with cervical cancer

Tekijä Polterauer, S, Grimm, C, Hofstetter, G, Concin, N, Natter, C, Sturdza, A, Pötter, R, Marth, C, Reinthaller, A, Heinze, G
Julkaistu 2012

Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.

Tekijä Marth, C., Widschwendter, M., Kaern, J., Jørgensen, N. P., Windbichler, G., Zeimet, A. G., Tropé, C., Daxenbichler, G.
Julkaistu 1997

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Canc...

Tekijä Harter, P., du Bois, A., Mahner, S., Pfisterer, J., Ortmann, O., Marth, C., Fink, D., Hilpert, F., Wagner, U., Sehouli, J.
Julkaisussa Geburtshilfe Frauenheilkd (2016)

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

Tekijä Windbichler, G H, Hausmaninger, H, Stummvoll, W, Graf, A H, Kainz, C, Lahodny, J, Denison, U, Müller-Holzner, E, Marth, C
Julkaistu 2000

Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro

Tekijä Widschwendter, M, Widschwendter, A, Welte, T, Daxenbichler, G, Zeimet, A G, Bergant, A, Berger, J, Peyrat, J-P, Michel, S, Doppler, W, Marth, C
Julkaistu 1999

Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial

Tekijä Seebacher, V, Polterauer, S, Grimm, C, Rahhal, J, Hofstetter, G, Bauer, E-M, Husslein, H, Leipold, H, Marth, C, Reinthaller, A, Concin, N
Julkaistu 2012

Network Analysis Guided Synthesis of Weisaconitine D and Liljestrandinine

Tekijä Marth, C. J., Gallego, G. M., Lee, J. C., Lebold, T. P., Kulyk, S., Kou, K. G. M., Qin, J., Lilien, R., Sarpong, R.
Julkaisussa Nature (2015)

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer...

Tekijä Wagner, U, Marth, C, Largillier, R, Kaern, J, Brown, C, Heywood, M, Bonaventura, T, Vergote, I, Piccirillo, M C, Fossati, R, Gebski, V, Lauraine, E P
Julkaistu 2012

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Tekijä Hofstetter, G, Berger, A, Schuster, E, Wolf, A, Hager, G, Vergote, I, Cadron, I, Sehouli, J, Braicu, E I, Mahner, S, Speiser, P, Marth, C, Zeimet, A G, Ulmer, H, Zeillinger, R, Concin, N
Julkaistu 2011

Axillary Dissection in the Case of Positive Sentinel Lymph Nodes: Results of the Innsbruck Consensus Conference

Tekijä Hubalek, M., Bartsch, R., Gnant, M., Kapp, K. S., Lang, A., Lax, S., Lukas, P., Neunteufel, W., Pristauz, G., Reitsamer, R., Sandbichler, P., Schrenk, P., Singer, C., Tamussino, K., Tschmelitsch, J., Zeimet, A. G., Marth, C.
Julkaistu 2012